Discover free eBooks, guides and med spa templates on our new resources page

ICD-11

ICD-11 Codes
for 2A00.00 - Glioblastoma of brain
Teodor Jurukovski January 1, 1970
Fact checked by: Teodor Jurukovski
Use Code

Understanding glioblastoma of brain

Glioblastoma of brain, classified under ICD-11 code 2A00.00, is a highly aggressive malignant astrocytic tumour designated as World Health Organization grade IV. It is the most common primary malignant brain tumour in adults and is associated with rapid progression and poor prognosis.

Although glioblastoma can occur at any age, it is most frequently diagnosed between 45 and 70 years of age. These tumours most commonly arise in the cerebral hemispheres but may develop in any region of the central nervous system. Their infiltrative growth pattern makes complete surgical removal difficult.

Common symptoms and clinical presentation

Symptoms of glioblastoma of brain often develop quickly and may initially be nonspecific. Clinical features are influenced by tumour location, associated brain oedema, and increased intracranial pressure.

Common symptoms
? Persistent headaches that may worsen in the morning or with coughing
? Nausea and vomiting related to raised intracranial pressure
? Personality changes, confusion, or memory impairment
? Focal neurological deficits such as speech or vision disturbance
? New onset seizures, particularly in adults without prior epilepsy

As the tumour enlarges, symptoms may progress rapidly and can include declining consciousness or acute neurological deterioration.

Causes and risk factors

The exact cause of most glioblastoma of brain cases remains unclear. Tumour development is believed to result from complex genetic and molecular alterations within astrocytic cells.

Risk factors
? Increasing age, with highest incidence in older adults
? Prior exposure to ionising radiation involving the head
? Inherited genetic syndromes such as neurofibromatosis or Li-Fraumeni syndrome

Diagnosis of glioblastoma of brain

Diagnosis involves correlation of clinical findings, neuroimaging, and pathological confirmation. Imaging studies are essential for assessing tumour extent and guiding surgical planning.

Magnetic resonance imaging is the preferred modality due to its ability to define tumour margins, necrosis, and surrounding oedema. Computed tomography may be used in emergency settings. Definitive diagnosis requires biopsy or surgical resection, allowing histopathological grading and molecular testing, which are critical for treatment planning and prognosis.

Treatment and management considerations

Management of glioblastoma of brain is complex due to its aggressive behaviour and infiltrative growth. Treatment is typically multimodal and aims to prolong survival, preserve neurological function, and manage symptoms.

Treatment approaches
? Surgical resection to reduce tumour burden when safely feasible
? Radiotherapy combined with chemotherapy such as temozolomide
? Supportive therapies including corticosteroids and anticonvulsants

Emerging therapies such as tumour treating fields and targeted molecular treatments are under active investigation and may be used in selected cases.

Synonyms and alternative terms

Glioblastoma of brain is commonly referred to by several alternative clinical terms. Recognition of these synonyms supports accurate documentation and continuity of care.

Alternative names
? Glioblastoma multiforme
? GBM
? Historical terms such as giant cell glioblastoma or gliosarcoma

Documentation and ICD-11 coding considerations

Accurate documentation is essential for clinical care, billing, and epidemiological reporting. Glioblastoma of brain should be coded using ICD-11 code 2A00.00. This code is billable and reportable when supported by appropriate diagnostic evidence.

Clinical notes should clearly document imaging findings, histopathological confirmation, and tumour grade. ICD-11 also allows postcoordination with additional codes to specify tumour location, laterality, or molecular features where relevant.

Are glioblastoma of brain ICD codes billable

Yes. ICD-11 code 2A00.00 is a billable diagnosis code. When supported by imaging and pathological confirmation, it may be used for reimbursement, clinical reporting, and healthcare analytics. Use of the most specific available code improves data accuracy and supports appropriate clinical and financial workflows.

Frequently asked questions

What is the ICD-11 code for Glioblastoma of brain?
The ICD-11 code for Glioblastoma of brain is 2A00.00. This code represents malignant astrocytic tumours, which are the most frequent brain tumours in adults.
How can Glioblastoma of brain be further detailed using ICD-11 post-coordination?
ICD-11 permits post-coordination for Glioblastoma of brain to add specificity. This can include details on laterality, specific anatomical location within the brain, histopathology such as IDH-wild type or IDH mutant, and associated manifestations.
What is the typical behaviour and grade associated with ICD-11 code 2A00.00?
For neoplasms coded under 2A00-2A0Z, including 2A00.00 Glioblastoma of brain, the behaviour is presumed malignant unless otherwise specified. Glioblastoma, IDH-wildtype, a subtype, is classified as WHO CNS grade 4.
How does ICD-11 handle unspecified cases of Glioblastoma of brain?
The ICD-11 code 2A00.00 includes 'glioblastoma NOS' (Not Otherwise Specified). ICD-11 utilizes 'unspecified' categories when necessary information for a more specific code is not available in the source documentation.
×